Compare ALEMBIC PHARMA with Unichem Lab - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALEMBIC PHARMA vs UNICHEM LAB - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALEMBIC PHARMA UNICHEM LAB ALEMBIC PHARMA/
UNICHEM LAB
 
P/E (TTM) x 16.0 -102.4 - View Chart
P/BV x 4.0 0.6 708.7% View Chart
Dividend Yield % 1.0 2.5 38.9%  

Financials

 ALEMBIC PHARMA   UNICHEM LAB
EQUITY SHARE DATA
    ALEMBIC PHARMA
Mar-19
UNICHEM LAB
Mar-19
ALEMBIC PHARMA/
UNICHEM LAB
5-Yr Chart
Click to enlarge
High Rs664292 227.4%   
Low Rs412182 226.6%   
Sales per share (Unadj.) Rs208.7167.7 124.5%  
Earnings per share (Unadj.) Rs31.0-3.6 -853.8%  
Cash flow per share (Unadj.) Rs37.15.9 624.6%  
Dividends per share (Unadj.) Rs5.504.00 137.5%  
Dividend yield (eoy) %1.01.7 60.5%  
Book value per share (Unadj.) Rs144.2372.3 38.7%  
Shares outstanding (eoy) m188.5270.38 267.9%   
Bonus/Rights/Conversions -ESOP-  
Price / Sales ratio x2.61.4 182.4%   
Avg P/E ratio x17.4-65.3 -26.6%  
P/CF ratio (eoy) x14.539.9 36.4%  
Price / Book Value ratio x3.70.6 586.2%  
Dividend payout %17.7-110.2 -16.1%   
Avg Mkt Cap Rs m101,46116,680 608.3%   
No. of employees `000NA2.6 0.0%   
Total wages/salary Rs m7,4672,393 312.0%   
Avg. sales/employee Rs ThNM4,535.2-  
Avg. wages/employee Rs ThNM919.8-  
Avg. net profit/employee Rs ThNM-98.2-  
INCOME DATA
Net Sales Rs m39,34711,801 333.4%  
Other income Rs m94984 9.5%   
Total revenues Rs m39,44112,785 308.5%   
Gross profit Rs m8,736-835 -1,046.3%  
Depreciation Rs m1,152674 171.0%   
Interest Rs m18475 244.8%   
Profit before tax Rs m7,493-600 -1,249.5%   
Minority Interest Rs m110-   
Prior Period Items Rs m-931 -13,257.1%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,568-343 -456.4%   
Profit after tax Rs m5,844-256 -2,286.9%  
Gross profit margin %22.2-7.1 -313.8%  
Effective tax rate %20.957.3 36.5%   
Net profit margin %14.9-2.2 -685.9%  
BALANCE SHEET DATA
Current assets Rs m19,57720,384 96.0%   
Current liabilities Rs m14,8965,029 296.2%   
Net working cap to sales %11.9130.1 9.1%  
Current ratio x1.34.1 32.4%  
Inventory Days Days90105 85.7%  
Debtors Days Days45135 33.6%  
Net fixed assets Rs m27,0979,023 300.3%   
Share capital Rs m377141 267.8%   
"Free" reserves Rs m26,81126,058 102.9%   
Net worth Rs m27,18826,199 103.8%   
Long term debt Rs m4,9930-   
Total assets Rs m47,77831,496 151.7%  
Interest coverage x41.7-7.0 -597.9%   
Debt to equity ratio x0.20-  
Sales to assets ratio x0.80.4 219.8%   
Return on assets %12.6-0.6 -2,203.6%  
Return on equity %21.5-1.0 -2,203.7%  
Return on capital %23.6-2.0 -1,180.5%  
Exports to sales %069.4 0.0%   
Imports to sales %00-   
Exports (fob) Rs mNA8,188 0.0%   
Imports (cif) Rs mNANA-   
Fx inflow Rs m19,4538,188 237.6%   
Fx outflow Rs m6,065596 1,017.6%   
Net fx Rs m13,3887,592 176.3%   
CASH FLOW
From Operations Rs m8,120-3,278 -247.7%  
From Investments Rs m-7,556-2,860 264.2%  
From Financial Activity Rs m590-24 -2,439.7%  
Net Cashflow Rs m1,153-4,690 -24.6%  

Share Holding

Indian Promoters % 74.1 50.1 147.9%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 2.9 15.1 19.2%  
FIIs % 9.1 3.0 303.3%  
ADR/GDR % 0.0 0.0 -  
Free float % 13.9 31.7 43.8%  
Shareholders   49,328 20,176 244.5%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALEMBIC PHARMA With:   CADILA HEALTHCARE  TTK HEALTHCARE  ORCHID PHARMA LTD  BIOCON   J.B.CHEMICALS  

Compare ALEMBIC PHARMA With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 21 Points Higher; Banking and Oil & Gas Stocks Witness Buying(Closing)

Indian share markets witnessed buying interest during closing hours today and ended their day marginally higher.

Related Views on News

ALEMBIC PHARMA Announces Quarterly Results (2QFY20); Net Profit Up 25.2% (Quarterly Result Update)

Nov 1, 2019 | Updated on Nov 1, 2019

For the quarter ended September 2019, ALEMBIC PHARMA has posted a net profit of Rs 3 bn (up 25.2% YoY). Sales on the other hand came in at Rs 12 bn (up 10.1% YoY). Read on for a complete analysis of ALEMBIC PHARMA's quarterly results.

ALEMBIC PHARMA Announces Quarterly Results (1QFY20); Net Profit Up 36.4% (Quarterly Result Update)

Aug 21, 2019 | Updated on Aug 21, 2019

For the quarter ended June 2019, ALEMBIC PHARMA has posted a net profit of Rs 1 bn (up 36.4% YoY). Sales on the other hand came in at Rs 9 bn (up 10.0% YoY). Read on for a complete analysis of ALEMBIC PHARMA's quarterly results.

UNICHEM LAB Announces Quarterly Results (1QFY20); Net Profit Up 102.2% (Quarterly Result Update)

Jul 30, 2019 | Updated on Jul 30, 2019

For the quarter ended June 2019, UNICHEM LAB has posted a net profit of Rs 5 m (up 102.2% YoY). Sales on the other hand came in at Rs 2 bn (up 15.4% YoY). Read on for a complete analysis of UNICHEM LAB's quarterly results.

UNICHEM LAB 2018-19 Annual Report Analysis (Annual Result Update)

Jul 4, 2019 | Updated on Jul 4, 2019

Here's an analysis of the annual report of UNICHEM LAB for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of UNICHEM LAB. Also includes updates on the valuation of UNICHEM LAB.

ALEMBIC PHARMA 2018-19 Annual Report Analysis (Annual Result Update)

Jun 13, 2019 | Updated on Jun 13, 2019

Here's an analysis of the annual report of ALEMBIC PHARMA for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of ALEMBIC PHARMA. Also includes updates on the valuation of ALEMBIC PHARMA.

More Views on News

Most Popular

Is Hawkins Set to Become Our Next Superhero Stock?(The 5 Minute Wrapup)

Nov 1, 2019

After PI Industries, Hawkins has put up a stellar show so far.

Crash Alert! Is There a Big Bubble in Nestle, HUL and Asian Paints?(Profit Hunter)

Nov 7, 2019

Is this the beginning of the end of multibagger gains in quality stocks like Nestle, HUL, and Asian Paints?

Ditch the Risky Fixed Deposits for Safer 'Bluechip Deposits'(Profit Hunter)

Oct 30, 2019

Most people think stocks are riskier than fixed deposits and bonds. The last quarter century proves otherwise.

The Top Stocks for 2020 Pass This Most Critical Metric(The 5 Minute Wrapup)

Nov 5, 2019

Charlie Munger's favorite fictional character, Mr Glotz, picks stocks using this metric.

What to Buy at Sensex 40,000(The 5 Minute Wrapup)

Nov 4, 2019

Should you invest in high-quality, safe stocks or make some contrarian bets in the smallcap space?

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

ALEMBIC PHARMA SHARE PRICE


Nov 11, 2019 (Close)

TRACK ALEMBIC PHARMA

  • Track your investment in ALEMBIC PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ALEMBIC PHARMA

ALEMBIC PHARMA 8-QTR ANALYSIS

COMPARE ALEMBIC PHARMA WITH

MARKET STATS